Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04676633
Title Open-Label Study for Safety, Tolerability, PK and Anti-Tumor Activity of STP705 Administered Intratumorally in Cholangiocarcinoma, Hepatocellular Carcinoma or Liver Metastases in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sirnaomics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Honor Health Scottsdale Arizona 85258 United States Details
USC Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Norton Cancer Institute Louisville Kentucky 40202 United States Details
Atlantic Health System Morristown New Jersey 07960 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field